Advancing Cancer Research for Latinos and All Populations Conference to Target Cancer in South Texas and Beyond

Share On Social!

To spur solutions that improve cancer care in South Texas and across the United States, UT Health San Antonio and its Mays Cancer Center are hosting the 5^th biennial Advancing Cancer Research for Latinos and All Populations conference on Feb. 18-20, 2026, at the Plaza San Antonio in San Antonio, Texas.

Advancing Cancer Research for Latinos and All Populations is expected to draw over 300 researchers, doctors, community leaders, and survivors for an open dialogue on the latest cancer research and how to improve cancer outcomes for all people.

Media is invited to attend.

“Advancing Cancer Research for Latinos and All Populations is where we gather to share timely research from every stage of the cancer continuum to improve genetic studies, clinical best practices, and community interventions,” said Dr. Amelie Ramirez, who founded the conference and directs UT Health San Antonio’s Institute for Health Promotion Research (IHPR).

Why Do We Need the Advancing Cancer Research for Latinos and All Populations Conference?

Although there has been substantial progress in cancer prevention, screening, diagnosis and treatment over past decades, cancer remains a top cause of death in the US.

Incidence rates are increasing for several cancers associated with obesity, including breast, uterus, colon, pancreas, kidney, and liver cancers.

In addition, colon cancer is now the top killer among Americans younger than 50.

“Our conference will bring together cancer experts from across the nation to examine the factors contributing to cancer and advance precision medicine,” Ramirez said.

Who Is Speaking at the Advancing Cancer Research for Latinos and All Populations Conference?

Advancing Cancer Research for Latinos and All Populations speakers from Feb. 18-20 include:

• Robert A. Winn, MD. VCU Massey Comprehensive Cancer Center. He will focus on how to prioritize cancer research and uplifting voices in the face of challenges.
• Lei Zheng, MD, PhD. Mays Cancer Center at UT Health San Antonio. He will share local efforts to address the cancer burden in South Texas.
• Leticia Nogueira, PhD, MPH. American Cancer Society. She will explore how extreme weather events can impact cancer control.
• Eliseo J. Pérez-Stable, MD. Former Leader, National Institute on Minority Health and Health Disparities at the National Institutes of Health. He will focus on tobacco cessation.
• Frank Penedo, PhD. University of Miami Sylvester Comprehensive Cancer Center. He will focus on cancer survivorship issues.
• Sukeshi Patel Arora, MD. UT Health San Antonio. She will focus on liver and colorectal cancer research.
• Mariana Chavez MacGregor, MD. MD Anderson Cancer Center. She will focus on bridging national and international cancer research efforts.
• Narjust Florez, MD. Dana-Farber Brigham Cancer Center / Florez Lab. She will focus on lung cancer treatment, research, and fairness in younger women.
• Ruben A. Mesa, MD. Atrium Health Wake Forest Baptist Comprehensive Cancer Center. He will focus on Cancer Center efforts to spur cancer research.
• Carlos L. Arteaga, MD. Harold C. Simmons Comprehensive Cancer Center at UT Southwestern. He will focus on Cancer Center efforts to spur cancer research.
• Laura Ortiz‑Ravick, MA. Blood Cancer United. She will explore how to galvanize communities to address challenges to cancer care.
• Elena V. Rios, MD. National Hispanic Health Foundation. She will focus on the public policy implications of cancer and access to care.

“These and other presenters will unveil new lab research, clinical innovations, and community projects to stimulate multidisciplinary collaborations for cancer solutions that touch on genetics, biological issues, screening, and how to address the non-medical drivers of health that impact incidence and mortality rates and survivorship,” Ramirez said.

Who Is Behind the Advancing Cancer Research for Latinos and All Populations Conference?

The conference scientific planning committee is led by chair, Amelie G. Ramirez, DrPH, UT Health San Antonio, and co-chairs, Edward J. Trapido, ScD, FACE, dean and professor, Louisiana State University School of Public Health, and Marcela Mazo Canola, MD, assistant professor, UT Health San Antonio.

The rest of the committee includes:

• Barbara Segarra-Vázquez, DHSc, MT, University of Puerto Rico
• Alejandro Recio Boiles, MD, FACP, University of Arizona
• Maria Constanza Camargo, PhD, National Cancer Institute
• Janeth Sanchez, PhD, National Cancer Institute
• Gerardo Colon-Otero, MD, Mayo Clinic, Florida
• Katherine Y. Tossas, PhD, MS, Virginia Commonwealth University
• Mariana C. Stern, PhD, University of Southern California
• Martin Mendoza, PhD, Population Health Leader
• Matthew P. Banegas, PhD, MPH, University of California, San Diego
• Patricia I. Moreno, PhD, University of Miami
• Yamilé Molina, PhD, University of Illinois
• Laura Fejerman, MSc, PHD, University of California, Davis
• Mary Jimenez, Community Advisory Board, Mays Cancer Center
• Sandi Stanford, Alamo Breast Cancer Foundation

Conference sponsors include: AstraZeneca, Bristol Myers Squibb, Genentech, Gilead, Revolution Medicine, Natera (platinum); Blood Cancer United, Menarini Stemline, Eli Lilly (gold); National Hispanic Health Foundation, American Cancer Society, STEAM Network (silver); and University of New Mexico, Sylvester Comprehensive Cancer Center (amigos).

Also, on Feb. 17, the day before the start of Advancing Cancer Research for Latinos and All Populations, conference leaders will host the second Cancer Patient Leadership Training Program.

The training program is a day-long event to guide 16 cancer survivors, including several from Texas, to become patient leaders to speak up for patients and research volunteers.

Each trainee will then attend the conference to enhance their knowledge of cancer research.

The training program is led by Dr. Barbara Segarra-Vázquez of the University of Puerto Rico and Sandi Stanford of the Alamo Breast Cancer Foundation and a member of the Community Advisory Board of the Mays Cancer Center. Program sponsors include Exact Sciences, Bristol Myers Squibb, and Pfizer.

“Our committee and sponsors are excited to celebrate patient leaders and explore new research advancements and collaborations from bench to bedside to survivorship,” Ramirez said.

For more information and to register, visit https://uthscsa.edu/medicine/education/cme/conferences/acr.

The conference hashtags are: #CancerResearchForAll #ACRLP